<SEC-DOCUMENT>0001213900-20-006233-index.html : 20200313
<SEC-HEADER>0001213900-20-006233.hdr.sgml : 20200313
<ACCEPTANCE-DATETIME>20200313121930
ACCESSION NUMBER:		0001213900-20-006233
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20200313
FILED AS OF DATE:		20200313
DATE AS OF CHANGE:		20200313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tiziana Life Sciences plc
		CENTRAL INDEX KEY:			0001723069
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38723
		FILM NUMBER:		20711554

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, 11-12 ST. JAMES'S SQUARE
		CITY:			LONDON, ENGLAND
		STATE:			X0
		ZIP:			SW1Y 4LB
		BUSINESS PHONE:		0044(0) 207-495-2379

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, 11-12 ST. JAMES'S SQUARE
		CITY:			LONDON, ENGLAND
		STATE:			X0
		ZIP:			SW1Y 4LB
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea119588-6k_tizianalife.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea119588-6k_tizianalife.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea119588ex1-1_tizianalife.htm
<DESCRIPTION>FORM OF UNDERWRITING AGREEMENT
<TEXT>
Document 2 - file: ea119588ex1-1_tizianalife.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea119588ex5-1_tizianalife.htm
<DESCRIPTION>OPINION OF ORRICK, HERRINGTON & SUTCLIFFE (UK) LLP
<TEXT>
Document 3 - file: ea119588ex5-1_tizianalife.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea119588ex99-1_tizianalife.htm
<DESCRIPTION>PRESS RELEASE, DATED MARCH 11, 2020
<TEXT>
Document 4 - file: ea119588ex99-1_tizianalife.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: ex5-1_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>